Pelthos Therapeutics share price logo

Pelthos Therapeutics

AMEX: PTHS

$8.07

-1.32

(-14.06%)

as on

Pelthos Therapeutics Stock Performance

as on November 13, 2026 at 7:59 am IST

  • Day's Low

    Day's High

    $7.84
    $9.45
    downward going graph

    2.85%

    Downside

    17.10%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $8.75
    $37.40
    downward going graph

    -8.43%

    Downside

    363.44%

    Upside

    downward going graph

Pelthos Therapeutics share price movements today

Previous Close
$9.39
Open
$9.45
Volume
333.2K
Market Cap
$36.8M
Day's Low - High
$7.84 - $9.45
52 Week Low - High
$8.75 - $37.40

Pelthos Therapeutics Historical Returns

1 Month Return
-56.59 %
3 Month Return
-68.91 %
1 Year Return
-73.03 %
3 Year Return
0 %
5 Year Return
0 %

Pelthos Therapeutics Stock Fundamentals & Key Indicators

Check Pelthos Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$36.8M

EPS (TTM)

-41.93

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.21

Industry PE ratio

-3.10

PEG Ratio

0.00

EBITDA

-62.6M

Revenue (TTM)

43.3M

Profit Margin

54.72%

Return On Equity TTM

-218.94%

Pelthos Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Pelthos Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$36.8MNA-0.2154.72%0.00%
Neutral$101.5B7.57%-35.4828.00%0.00%
StrongBuy$48.4BNA68.2588.39%0.00%
StrongBuy$138.9B192.08%34.9985.57%0.00%
Buy$94.7B52.00%19.5185.77%0.40%

Stock Returns calculator for Pelthos Therapeutics Stock including INR - Dollar returns

The Pelthos Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Pelthos Therapeutics investment value today

Current value as on today

₹25,959

Returns

-₹74,041

(-74.04%)

Returns from Pelthos Therapeutics Stock

-₹75,545 (-75.55%)

Dollar Impact

₹1,504 (+1.5%)

Analyst Recommendation on Pelthos Therapeutics Stock

Based on 3 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 3 analysts, 100% of analysts recommend a 'BUY' rating for Pelthos Therapeutics. Average target price of $50.6666666666667

Pelthos Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Pelthos Therapeutics.

Current Price

$8.07

Analyzed by

3 Analysts

High

$64

0

Low

$40

Pelthos Therapeutics target price $0, a slight upside of 0% compared to current price of $8.07. According to 3 analysts rating.

Indian Investors' Interest in Pelthos Therapeutics Stock

Search interest for Pelthos Therapeutics Stock has decreased by -16% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-16% versus previous 30 day period

Pelthos Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
7
9
10
15
Gross Profit
-
-
-
-
-
-
2
4
5
10
Operating Income
-1
-1
-2
-1
-1
-3
-15
-12
-13
-17
EBITDA
-1
-1
-1
-1
-1
-3
-14
-26
-6
-15
Interest Expense
0
0
0
0
0
0
1
1
2
2
Depreciation
-
-
-
-
-
-
1
1
1
1
Income Before Tax
-2
-1
-1
-1
-1
-3
-16
-28
-10
-23
Income Tax Expense
-
-
-
-
-
-
0
-6
-
-
Net Income
-2
-1
-1
-1
-1
-3
-16
-21
-10
-23
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
32.82%
53.24%
51.29%
68.40%

Pelthos Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
-
-
-
-
16
Gross Profit
0
0
-
-
-
7
Operating Income
-1
0
-2
-6
-7
-32
EBITDA
-
-
-2
-6
-7
-45
Interest Expense
0
0
0
0
0
3
Depreciation
1
0
-
-
-
2
Income Before Tax
0
0
-2
-7
-7
-50
Income Tax Expense
-1
0
-
-
-
-7
Net Income
0
0
-2
-7
-7
-43
Net Profit Margin
100.00%
0.00%
0.00%
0.00%
0.00%
44.24%

Pelthos Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-2
-1
-1
-1
-1
-3
-16
-21
-10
-23
Operating Cash Flow
-1
-2
0
0
0
0
-15
-6
-13
-7
Investing Cash Flow
-
-
-
-
-
-
2
-7
0
0
Financing Cash Flow
5
1
0
0
0
0
26
18
27
-
Change in Cash
3
-1
-1
0
0
0
14
3
14
-7

Pelthos Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
0
0
-2
-7
-7
-43
Operating Cash Flow
-3
-1
-1
0
-5
-22
Investing Cash Flow
-
-
-
-
-
-5
Financing Cash Flow
3
1
1
1
6
45
Change in Cash
-
-
0
0
0
17

Global Institutional Holdings in Pelthos Therapeutics

Check out the Institutions with significant holdings in Pelthos Therapeutics.

Funds
Holdings
Todd Davis
41.16%
Ligand Pharmaceuticals Inc
39.18%
Friedberg Ezra M
5.31%
VANGUARD INDEX FUNDS
2.46%
Vanguard
2.46%

Insights on Pelthos Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 831.1% return, outperforming this stock by 906.0%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, PTHS stock has moved down by -51.9%

About Pelthos Therapeutics

Pelthos Therapeutics Inc. operates as a biopharmaceutical enterprise dedicated to developing and commercializing innovative medical treatments that address significant, unmet patient needs. Its primary offerings include ZELSUVMI, a medication specifically indicated for the treatment of molluscum contagiosum in individuals aged one year and older. Furthermore, the company leverages NITRICIL, an exclusive technological platform grounded in nitric oxide research. Established in 2002, this Durham, North Carolina-based firm was previously known as Channel Therapeutics Corporation, before rebranding to Pelthos Therapeutics Inc. in July 2025.
OrganisationPelthos Therapeutics
Headquarters4020 Stirrup Creek Drive, Suite 110, Durham, NC 27703, Durham, NC, 27703, US
IndustryBiotechnology
CEOScott Plesha

Key Management of Pelthos Therapeutics

Name

Title

Mr. Scott M. Plesha

CEO, President & Director

Mr. Sai Rangarao M.B.A.

Chief Commercial Officer

Mr. John M. Gay CPA

CFO, Treasurer & Secretary

FAQs

What is Pelthos Therapeutics share price today?

Pelthos Therapeutics share price today is $8.07 as on at the close of the market. Pelthos Therapeutics share today touched a day high of $9.45 and a low of $7.84.

What is the 52 week high and 52 week low for Pelthos Therapeutics share?

Pelthos Therapeutics share touched a 52 week high of $37.40 on and a 52 week low of $8.75 on . Pelthos Therapeutics stock price today i.e. is closed at $8.07,which is 78.42% down from its 52 week high and -7.77% up from its 52 week low.

What is Pelthos Therapeutics's market capitalisation today?

Pelthos Therapeutics market capitalisation is $0.00T as on .

How to invest in Pelthos Therapeutics Stock (PTHS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Pelthos Therapeutics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Pelthos Therapeutics Stock (PTHS) from India?

Indian investors can start investing in Pelthos Therapeutics (PTHS) shares with as little as ₹94.04000091552734 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹940.40 in Pelthos Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Pelthos Therapeutics share’s latest price of $8.07 as on November 13, 2026 at 2:29 am IST, you will get 1.2392 shares of Pelthos Therapeutics. Learn more about fractional shares .